<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>Greenbackd &#187; Avigen (NASDAQ:AVGN)</title>
	<atom:link href="http://greenbackd.com/category/stocks/avigen-nasdaqavgn/feed/" rel="self" type="application/rss+xml" />
	<link>http://greenbackd.com</link>
	<description>Identifying undervalued asset situations with a catalyst</description>
	<lastBuildDate>Thu, 18 Mar 2010 07:30:39 +0000</lastBuildDate>
	<generator>http://wordpress.com/</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<cloud domain='greenbackd.com' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://www.gravatar.com/blavatar/45063ac3b5db5ca12793a9fed6517e9e?s=96&#038;d=http://s2.wp.com/i/buttonw-com.png</url>
		<title>Greenbackd &#187; Avigen (NASDAQ:AVGN)</title>
		<link>http://greenbackd.com</link>
	</image>
	<atom:link rel="search" type="application/opensearchdescription+xml" href="http://greenbackd.com/osd.xml" title="Greenbackd" />
	<atom:link rel='hub' href='http://greenbackd.com/?pushpress=hub'/>
		<item>
		<title>AVGN releases terms of MNOV deal; Shareholder launches class action</title>
		<link>http://greenbackd.com/2009/08/27/avgn-releases-terms-of-mnov-deal-directors-sued-by-shareholder/</link>
		<comments>http://greenbackd.com/2009/08/27/avgn-releases-terms-of-mnov-deal-directors-sued-by-shareholder/#comments</comments>
		<pubDate>Thu, 27 Aug 2009 05:00:58 +0000</pubDate>
		<dc:creator>greenbackd</dc:creator>
				<category><![CDATA[Activist Investors]]></category>
		<category><![CDATA[Avigen (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Biotechnology Value Fund]]></category>
		<category><![CDATA[Net Cash Stocks]]></category>
		<category><![CDATA[Stocks]]></category>
		<category><![CDATA[Activist investment]]></category>
		<category><![CDATA[Avigen Inc (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Liquidation Value]]></category>
		<category><![CDATA[Net Cash Stock]]></category>

		<guid isPermaLink="false">http://greenbackd.com/?p=2310</guid>
		<description><![CDATA[Although we closed our position in Avigen Inc (NASDAQ:AVGN) earlier this week, we&#8217;re keeping a watching brief on the stock. AVGN has now filed with the SEC the terms of the deal with MediciNova Inc (NASDAQ:MNOV), and they&#8217;re not as bad as the earlier report seemed to suggest. The deal has, however, attracted the ire [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=greenbackd.com&blog=5581605&post=2310&subd=greenbackd&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://greenbackd.com/2009/08/27/avgn-releases-terms-of-mnov-deal-directors-sued-by-shareholder/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">greenbackd</media:title>
		</media:content>
	</item>
		<item>
		<title>MNOV to acquire AVGN for $1.24 per share; Greenbackd exits</title>
		<link>http://greenbackd.com/2009/08/24/mnov-to-acquire-avgn-for-1-24-per-share-greenbackd-exits/</link>
		<comments>http://greenbackd.com/2009/08/24/mnov-to-acquire-avgn-for-1-24-per-share-greenbackd-exits/#comments</comments>
		<pubDate>Mon, 24 Aug 2009 05:00:28 +0000</pubDate>
		<dc:creator>greenbackd</dc:creator>
				<category><![CDATA[Activist Investors]]></category>
		<category><![CDATA[Avigen (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Biotechnology Value Fund]]></category>
		<category><![CDATA[Net Cash Stocks]]></category>
		<category><![CDATA[Stocks]]></category>
		<category><![CDATA[Activist investment]]></category>
		<category><![CDATA[Avigen Inc (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Liquidation Value]]></category>
		<category><![CDATA[Net Cash Stock]]></category>

		<guid isPermaLink="false">http://greenbackd.com/?p=2287</guid>
		<description><![CDATA[MediciNova Inc. (NASDAQ:MNOV) will acquire Avigen Inc (NASDAQ:AVGN) for $1.24 per share in cash or secured convertible notes. While the stock is trading at a slight premium to the bid, we&#8217;re taking the opportunity to exit. AVGN closed Friday at $1.29, which means we&#8217;re up 98.5% on an absolute basis. The S&#38;P500 was at 816.21 [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=greenbackd.com&blog=5581605&post=2287&subd=greenbackd&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://greenbackd.com/2009/08/24/mnov-to-acquire-avgn-for-1-24-per-share-greenbackd-exits/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">greenbackd</media:title>
		</media:content>
	</item>
		<item>
		<title>Avigen Inc (NASDAQ:AVGN) Q2 10Q update</title>
		<link>http://greenbackd.com/2009/08/18/avigen-inc-nasdaqavgn-q2-10q-update/</link>
		<comments>http://greenbackd.com/2009/08/18/avigen-inc-nasdaqavgn-q2-10q-update/#comments</comments>
		<pubDate>Tue, 18 Aug 2009 05:00:37 +0000</pubDate>
		<dc:creator>greenbackd</dc:creator>
				<category><![CDATA[Activist Investors]]></category>
		<category><![CDATA[Avigen (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Biotechnology Value Fund]]></category>
		<category><![CDATA[Net Cash Stocks]]></category>
		<category><![CDATA[Stocks]]></category>
		<category><![CDATA[Activist investment]]></category>
		<category><![CDATA[Avigen Inc (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Net Cash Stock]]></category>
		<category><![CDATA[Liquidation Value]]></category>

		<guid isPermaLink="false">http://greenbackd.com/?p=2249</guid>
		<description><![CDATA[Avigen Inc (NASDAQ:AVGN) has filed its 10Q for the period ended June 30, 2009.
One interesting aspect of the 10Q is the cost the company attributes to responding to the proxy fight and hostile tender offer:
Operating Activities. Net cash used in operating activities was $8.2 million during the six months ended June 30, 2009. Net cash [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=greenbackd.com&blog=5581605&post=2249&subd=greenbackd&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://greenbackd.com/2009/08/18/avigen-inc-nasdaqavgn-q2-10q-update/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">greenbackd</media:title>
		</media:content>

		<media:content url="http://greenbackd.files.wordpress.com/2009/08/avgn-summary-2009-6-30.png" medium="image">
			<media:title type="html">AVGN Summary 2009 6 30</media:title>
		</media:content>
	</item>
		<item>
		<title>AVGN merger with MediciNova back on the table</title>
		<link>http://greenbackd.com/2009/07/21/avgn-merger-with-medicinova-back-on-the-table-greenbackd-exits/</link>
		<comments>http://greenbackd.com/2009/07/21/avgn-merger-with-medicinova-back-on-the-table-greenbackd-exits/#comments</comments>
		<pubDate>Tue, 21 Jul 2009 05:00:36 +0000</pubDate>
		<dc:creator>greenbackd</dc:creator>
				<category><![CDATA[Activist Investors]]></category>
		<category><![CDATA[Avigen (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Biotechnology Value Fund]]></category>
		<category><![CDATA[Greenbackd Portfolio]]></category>
		<category><![CDATA[Liquidation Value]]></category>
		<category><![CDATA[Net Cash Stocks]]></category>
		<category><![CDATA[Stocks]]></category>
		<category><![CDATA[Activist investment]]></category>
		<category><![CDATA[Avigen Inc (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Net Cash Stock]]></category>

		<guid isPermaLink="false">http://greenbackd.com/?p=2078</guid>
		<description><![CDATA[Avigen Inc (NASDAQ:AVGN) is back in negotiations with MediciNova, Inc. regarding a proposed acquisition of AVGN by MediciNova. The consideration for the deal is AVGN&#8217;s &#8220;net cash liquidation value plus $3 million&#8221; and &#8220;a contingent payment right for a specific product program milestone payment associated with Avigen&#8217;s Assignment Agreement with Genzyme Corporation, potentially subject to [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=greenbackd.com&blog=5581605&post=2078&subd=greenbackd&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://greenbackd.com/2009/07/21/avgn-merger-with-medicinova-back-on-the-table-greenbackd-exits/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">greenbackd</media:title>
		</media:content>
	</item>
		<item>
		<title>Greenbackd Portfolio Q2 Performance and Update</title>
		<link>http://greenbackd.com/2009/06/01/greenbackd-portfolio-q2-performance-and-update/</link>
		<comments>http://greenbackd.com/2009/06/01/greenbackd-portfolio-q2-performance-and-update/#comments</comments>
		<pubDate>Mon, 01 Jun 2009 06:16:39 +0000</pubDate>
		<dc:creator>greenbackd</dc:creator>
				<category><![CDATA[About]]></category>
		<category><![CDATA[Autobytel (NASDAQ:ABTL)]]></category>
		<category><![CDATA[Avigen (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Axcelis Technologies Inc (NASDAQ:ACLS)]]></category>
		<category><![CDATA[Ditech Networks Inc (NASDAQ:DITC)]]></category>
		<category><![CDATA[Greenbackd]]></category>
		<category><![CDATA[Greenbackd Portfolio]]></category>
		<category><![CDATA[Liquidation Value]]></category>
		<category><![CDATA[MathStar Inc (OTC:MATH)]]></category>
		<category><![CDATA[Network Engines Inc (NASDAQ:NENG)]]></category>
		<category><![CDATA[Neurobiological Technologies Inc (NASDAQ:NTII)]]></category>
		<category><![CDATA[Northstar Neuroscience Inc (NASDAQ:NSTR)]]></category>
		<category><![CDATA[Rackable Systems Inc (NASDAQ:RACK)]]></category>
		<category><![CDATA[Soapstone Networks Inc (NASDAQ:SOAP)]]></category>
		<category><![CDATA[Stocks]]></category>
		<category><![CDATA[Vanda Pharmaceuticals Inc (NASDAQ:VNDA)]]></category>
		<category><![CDATA[VaxGen Inc (OTC:VXGN)]]></category>
		<category><![CDATA[Activist investment]]></category>
		<category><![CDATA[Autobytel Inc (NASDAQ:ABTL)]]></category>
		<category><![CDATA[Avigen Inc (NASDAQ:AVGN)]]></category>

		<guid isPermaLink="false">http://greenbackd.com/?p=1930</guid>
		<description><![CDATA[Update June 16, 2009: SOAP has announced that it proposes to liquidate. See our post below.
Update June 3, 2009: We&#8217;ve pinned this post to the front page. Any new posts between now and July 4th will appear below this post.
&#8212;
June 1, 2009 marked the end of Greenbackd’s second quarter. It&#8217;s time again to report on [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=greenbackd.com&blog=5581605&post=1930&subd=greenbackd&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://greenbackd.com/2009/06/01/greenbackd-portfolio-q2-performance-and-update/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">greenbackd</media:title>
		</media:content>

		<media:content url="http://greenbackd.files.wordpress.com/2009/06/greenbackd-portfolio-performance-2009-q2.png" medium="image">
			<media:title type="html">Greenbackd Portfolio Performance 2009 Q2</media:title>
		</media:content>
	</item>
		<item>
		<title>Avigen granted AV411 patent</title>
		<link>http://greenbackd.com/2009/05/22/avigen-granted-av411-patent/</link>
		<comments>http://greenbackd.com/2009/05/22/avigen-granted-av411-patent/#comments</comments>
		<pubDate>Fri, 22 May 2009 05:00:31 +0000</pubDate>
		<dc:creator>greenbackd</dc:creator>
				<category><![CDATA[Activist Investors]]></category>
		<category><![CDATA[Avigen (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Biotechnology Value Fund]]></category>
		<category><![CDATA[Stocks]]></category>
		<category><![CDATA[Activist investment]]></category>
		<category><![CDATA[Avigen Inc (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Liquidation Value]]></category>

		<guid isPermaLink="false">http://greenbackd.com/?p=1939</guid>
		<description><![CDATA[Avigen Inc (NASDAQ:AVGN) has been granted a United States Patent for the treatment of neuropathic pain with its AV411 (ibudilast) compound.
We started following AVGN in December last year (see archived posts here) because it was a net cash stock (i.e. it was trading at less than the value of its cash after deducting all liabilities), [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=greenbackd.com&blog=5581605&post=1939&subd=greenbackd&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://greenbackd.com/2009/05/22/avigen-granted-av411-patent/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">greenbackd</media:title>
		</media:content>
	</item>
		<item>
		<title>Avigen Inc (NASDAQ:AVGN) Q1 10Q update</title>
		<link>http://greenbackd.com/2009/05/14/avigen-inc-nasdaqavgn-q1-10q-update/</link>
		<comments>http://greenbackd.com/2009/05/14/avigen-inc-nasdaqavgn-q1-10q-update/#comments</comments>
		<pubDate>Thu, 14 May 2009 05:00:22 +0000</pubDate>
		<dc:creator>greenbackd</dc:creator>
				<category><![CDATA[Activist Investors]]></category>
		<category><![CDATA[Avigen (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Biotechnology Value Fund]]></category>
		<category><![CDATA[Net Cash Stocks]]></category>
		<category><![CDATA[Stocks]]></category>
		<category><![CDATA[Activist investment]]></category>
		<category><![CDATA[Avigen Inc (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Liquidation Value]]></category>

		<guid isPermaLink="false">http://greenbackd.com/?p=1878</guid>
		<description><![CDATA[Avigen Inc (NASDAQ:AVGN) has filed its 10Q for the period ended March 31, 2009.
We started following AVGN in December last year (see archived posts here) because it was a net cash stock (i.e. it was trading at less than the value of its cash after deducting all liabilities), albeit a cash burning net cash stock, [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=greenbackd.com&blog=5581605&post=1878&subd=greenbackd&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://greenbackd.com/2009/05/14/avigen-inc-nasdaqavgn-q1-10q-update/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">greenbackd</media:title>
		</media:content>

		<media:content url="http://greenbackd.files.wordpress.com/2009/05/avgn-summary-2009-3-31.png" medium="image">
			<media:title type="html">AVGN Summary 2009 3 31</media:title>
		</media:content>
	</item>
		<item>
		<title>List of activist investments for March</title>
		<link>http://greenbackd.com/2009/04/13/list-of-activist-investments-for-march/</link>
		<comments>http://greenbackd.com/2009/04/13/list-of-activist-investments-for-march/#comments</comments>
		<pubDate>Mon, 13 Apr 2009 05:02:15 +0000</pubDate>
		<dc:creator>greenbackd</dc:creator>
				<category><![CDATA[Activist Investors]]></category>
		<category><![CDATA[Avigen (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Biotechnology Value Fund]]></category>
		<category><![CDATA[CuraGen Corporation (NASDAQ:CRGN)]]></category>
		<category><![CDATA[DellaCamera Capital Management]]></category>
		<category><![CDATA[Stocks]]></category>
		<category><![CDATA[Activist investment]]></category>
		<category><![CDATA[Avigen Inc (NASDAQ:AVGN)]]></category>

		<guid isPermaLink="false">http://greenbackd.com/?p=1651</guid>
		<description><![CDATA[The Official Activist Investing Blog has published its list of activist investments for March (links are to the relevant post archive for our open positions):



Ticker
Company
Investor


ACTL
Actel Corp
Ramius Capital


AGYS
Agilysys Inc
Ramius Capital


AMLN
Amylin Pharmaceuticals
Eastbourne Capital


ASPM
Aspect Medical Systems
First Manhattan Co


ASPM
Aspect Medical Systems
Coghill Capital


AVCA
Advocat Inc.
Bristol Investment Fund


AVGN
Avigen Inc
Biotechnology Value Fund


BARI
Bancorp Rhode Island
Financial Edge Fund


BASI
Bioanalytical Systems
Thomas Harenburg


BBI
Blockbuster Inc.
Mark Wattles


BBW
Build-A-Bear Workshop
Crescendo Capital


BNV
Beverly National [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=greenbackd.com&blog=5581605&post=1651&subd=greenbackd&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://greenbackd.com/2009/04/13/list-of-activist-investments-for-march/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">greenbackd</media:title>
		</media:content>
	</item>
		<item>
		<title>BVF fails to tip AVGN board</title>
		<link>http://greenbackd.com/2009/03/30/bvf-fails-to-tip-avgn-board/</link>
		<comments>http://greenbackd.com/2009/03/30/bvf-fails-to-tip-avgn-board/#comments</comments>
		<pubDate>Mon, 30 Mar 2009 05:01:52 +0000</pubDate>
		<dc:creator>greenbackd</dc:creator>
				<category><![CDATA[Activist Investors]]></category>
		<category><![CDATA[Avigen (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Biotechnology Value Fund]]></category>
		<category><![CDATA[Net Cash Stocks]]></category>
		<category><![CDATA[Stocks]]></category>
		<category><![CDATA[Liquidating Value]]></category>
		<category><![CDATA[Activist investment]]></category>
		<category><![CDATA[Avigen Inc (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Net Cash Stock]]></category>

		<guid isPermaLink="false">http://greenbackd.com/?p=1535</guid>
		<description><![CDATA[Biotechnology Value Fund (BVF) failed in its bid to remove Avigen Inc&#8217;s (NASDAQ:AVGN) board at Friday&#8217;s special meeting of stockholders, despite 58% of stockholders voting in favor of removing the board and only 12% voting in favor of retaining the incumbents.
The outcome highlights the difficulties faced by stockholders in selecting rival slates of directors. To [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=greenbackd.com&blog=5581605&post=1535&subd=greenbackd&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://greenbackd.com/2009/03/30/bvf-fails-to-tip-avgn-board/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">greenbackd</media:title>
		</media:content>
	</item>
		<item>
		<title>AVGN ends merger discussions; terminates CEO and other officers</title>
		<link>http://greenbackd.com/2009/03/27/avgn-ends-merger-discussions-terminates-ceo-and-other-officers/</link>
		<comments>http://greenbackd.com/2009/03/27/avgn-ends-merger-discussions-terminates-ceo-and-other-officers/#comments</comments>
		<pubDate>Fri, 27 Mar 2009 05:10:45 +0000</pubDate>
		<dc:creator>greenbackd</dc:creator>
				<category><![CDATA[Activist Investors]]></category>
		<category><![CDATA[Avigen (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Biotechnology Value Fund]]></category>
		<category><![CDATA[Net Cash Stocks]]></category>
		<category><![CDATA[Stocks]]></category>
		<category><![CDATA[Liquidating Value]]></category>
		<category><![CDATA[Activist investment]]></category>
		<category><![CDATA[Avigen Inc (NASDAQ:AVGN)]]></category>
		<category><![CDATA[Net Cash Stock]]></category>

		<guid isPermaLink="false">http://greenbackd.com/?p=1521</guid>
		<description><![CDATA[Avigen Inc (NASDAQ:AVGN) has discontinued its merger discussions and terminated its Chief Executive Officer and President, Kenneth Chahine, its Chief Business Officer, Michael Coffee, and its General Counsel, M. Christina Thomson, ahead of the special meeting of stockholders to be held today. Stockholders are to vote on  BVF’s proposal to remove the board of [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=greenbackd.com&blog=5581605&post=1521&subd=greenbackd&ref=&feed=1" />]]></description>
		<wfw:commentRss>http://greenbackd.com/2009/03/27/avgn-ends-merger-discussions-terminates-ceo-and-other-officers/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">greenbackd</media:title>
		</media:content>
	</item>
	</channel>
</rss>